Rise in prevalence of atrial fibrillation, stroke, and venous thromboembolism along with increase in obese population drive the global anticoagulants market
PORTLAND, Oregon, March 17, 2020 /PRNewswire/ -- Allied Market Research published a report, titled, "Anticoagulants Market by Drug Class (NOACs, Heparin & LMWH, Vitamin K Antagonist, and Others), Route of Administration (Oral Anticoagulant and Injectable Anticoagulant), and Application (Atrial Fibrillation & Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025." According to the report, the global anticoagulants market generated $26.11 billion in 2018, and is projected to generate $43.42 billion by 2025, registering a CAGR of 7.5% from 2018 to 2025.
Rise in prevalence of atrial fibrillation, stroke, and venous thromboembolism along with increase in obese population drive the global anticoagulants market. However, less demand from underdeveloped countries and expensive cost of NOACs restrain the market growth. On the other hand, untapped potential in emerging economies and rise in healthcare expenditure across the globe present new opportunities in coming years.
Based on the drug class, the NOACs segment held more than half of the total share of the global anticoagulants market in 2018, and is estimated to maintain its leadership position in terms of revenue during the forecast period. Moreover, this segment is expected to witness the highest CAGR of 8.0% from 2018 to 2025. The report also analyzes segments including heparins & LMWH, vitamin K antagonists, and others.
Based on route of administration, the oral anticoagulants segment accounted for the highest share in 2018, holding nearly two-thirds of the total share of the global anticoagulants market. Moreover, this segment is estimated to register the highest CAGR of 7.7% from 2018 to 2025. The report also discusses the injectable anticoagulants segment.
Based on application, the atrial fibrillation & heart attack segment held the largest share in 2018, accounting for more than two-fifths of the total share of the global market, and will maintain its dominant position by 2025. However, the deep vein thrombosis (DVT) segment is expected to maintain the largest growth rate with a CAGR of 8.4% during the forecast period.
Geographically, North America contributed to nearly half of the total share of the global anticoagulants market in 2018, and is expected to maintain its lead position on the basis of revenue during the forecast period. However, Asia-Pacific is estimated to witness the highest CAGR of 9.2% from 2019 to 2026.
Leading market players analyzed in the research include Aspen Holdings, Boehringer Ingelheim GmbH, Bayer AG, Daiichi Sankyo Company, Limited, Bristol-Myers Squibb Company, Johnson & Johnson (Janssen Pharmaceuticals, Inc.), GlaxoSmithKline plc., Portola Pharmaceuticals, Inc., Pfizer, Inc., and Sanofi S.A.
Avenue Basic Plan | Library Access | 1 Year Subscription
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.